exclusive | biocon biologics q4: serum will double investment to $300 mn
Published 1 year ago • 1K plays • Length 14:18Download video MP4
Download video MP3
Similar videos
-
5:24
serum takes its investment in biocon bio to $300 million, kiran m shaw on this & more | cnbc-tv18
-
19:14
adar poonawalla on serum's $ 300 m investment in biocon biologics | trading hour | cnbc-tv18
-
0:56
biocon limited company profile and tech intelligence report, 2018
-
1:15
nano-bio optics lab - prof. yoav shechtman
-
21:04
showcase biosurveillance
-
3:41
kiran mazumdar - shaw interacted with young women from the manufacturing shopfloor.
-
![#biochat @ isbp 2024 with dr. manoj lakshmanan [zacros]](https://i.ytimg.com/vi/QxW7OUW-mAA/mqdefault.jpg)
16:03
#biochat @ isbp 2024 with dr. manoj lakshmanan [zacros]
-
1:10
highlights of #q3fy21
-
0:19
biocon ltd: pharma leader in biotech & innovation |#stockmarket #investing | @iminfographics
-
2:08
biocon biologics is well-placed to take advantage of opportunities in the biosimilars space: ceo
-
6:02
biocon malaysia overview
-
5:11
biocellix
-
1:49
introducing venture lab cohort 4
-
7:56
biocon q4: muted growth in generic business | review by kiran mazumdar shaw | business news
-
2:35
strong biosimilar growth powers biocon | trading hour | cnbc tv18
-
10:48
q4 review | biocon march quarter net profit soars | bq prime
-
6:50
biocon's kiran mazumdar shaw on strong q4, biosimilar business & fy24 outlook | halftime report